nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylpropion—Electrocardiogram change—Teniposide—lymphatic system cancer	0.0656	0.0656	CcSEcCtD
Diethylpropion—Bone marrow depression—Teniposide—lymphatic system cancer	0.0278	0.0278	CcSEcCtD
Diethylpropion—Digestion impaired—Fludarabine—lymphatic system cancer	0.0247	0.0247	CcSEcCtD
Diethylpropion—Bone marrow depression—Fludarabine—lymphatic system cancer	0.0244	0.0244	CcSEcCtD
Diethylpropion—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Diethylpropion—Bone marrow depression—Vincristine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Diethylpropion—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Diethylpropion—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Diethylpropion—Alopecia—Mechlorethamine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Diethylpropion—Pancytopenia—Teniposide—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Diethylpropion—Sweating increased—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Diethylpropion—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Diethylpropion—Pancytopenia—Fludarabine—lymphatic system cancer	0.00982	0.00982	CcSEcCtD
Diethylpropion—Dysuria—Fludarabine—lymphatic system cancer	0.00967	0.00967	CcSEcCtD
Diethylpropion—Gynaecomastia—Carmustine—lymphatic system cancer	0.00944	0.00944	CcSEcCtD
Diethylpropion—Urine output increased—Vincristine—lymphatic system cancer	0.0091	0.0091	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Diethylpropion—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.00887	0.00887	CcSEcCtD
Diethylpropion—Arrhythmia—Teniposide—lymphatic system cancer	0.00841	0.00841	CcSEcCtD
Diethylpropion—Polyuria—Vincristine—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Diethylpropion—Alopecia—Teniposide—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Diethylpropion—Agitation—Teniposide—lymphatic system cancer	0.00753	0.00753	CcSEcCtD
Diethylpropion—Arrhythmia—Fludarabine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Diethylpropion—Leukopenia—Teniposide—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Diethylpropion—Alopecia—Fludarabine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Diethylpropion—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Diethylpropion—Pancytopenia—Bleomycin—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Diethylpropion—Chest pain—Teniposide—lymphatic system cancer	0.00698	0.00698	CcSEcCtD
Diethylpropion—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00668	0.00668	CcSEcCtD
Diethylpropion—Agitation—Fludarabine—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Diethylpropion—Tachycardia—Teniposide—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Diethylpropion—Malaise—Fludarabine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Diethylpropion—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Diethylpropion—Leukopenia—Fludarabine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Diethylpropion—Pancytopenia—Carmustine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Diethylpropion—Convulsion—Fludarabine—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Diethylpropion—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Diethylpropion—Myalgia—Fludarabine—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Diethylpropion—Discomfort—Fludarabine—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Diethylpropion—Pancytopenia—Vincristine—lymphatic system cancer	0.006	0.006	CcSEcCtD
Diethylpropion—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Diethylpropion—Dyspnoea—Teniposide—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Diethylpropion—Dysuria—Vincristine—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Diethylpropion—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Diethylpropion—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Diethylpropion—Vomiting—Mechlorethamine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Diethylpropion—Rash—Mechlorethamine—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Diethylpropion—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Diethylpropion—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Diethylpropion—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Diethylpropion—Feeling abnormal—Teniposide—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Diethylpropion—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Diethylpropion—Nausea—Mechlorethamine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Diethylpropion—Alopecia—Bleomycin—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Diethylpropion—Urticaria—Teniposide—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Diethylpropion—Erythema—Bleomycin—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Diethylpropion—Dyspnoea—Fludarabine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Diethylpropion—Dyspepsia—Fludarabine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Diethylpropion—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Diethylpropion—Constipation—Fludarabine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Diethylpropion—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Diethylpropion—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Diethylpropion—Malaise—Bleomycin—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Diethylpropion—Arrhythmia—Carmustine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Diethylpropion—Leukopenia—Bleomycin—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Diethylpropion—Alopecia—Carmustine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Diethylpropion—Erythema—Carmustine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Diethylpropion—Diarrhoea—Teniposide—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Diethylpropion—Myalgia—Bleomycin—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Diethylpropion—Chest pain—Bleomycin—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Diethylpropion—Alopecia—Vincristine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Diethylpropion—Discomfort—Bleomycin—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Diethylpropion—Ecchymosis—Methotrexate—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Diethylpropion—Urine output increased—Methotrexate—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Diethylpropion—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Diethylpropion—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Diethylpropion—Alopecia—Mitoxantrone—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Diethylpropion—Vision blurred—Carmustine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Diethylpropion—Tremor—Carmustine—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Diethylpropion—Erythema—Mitoxantrone—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Diethylpropion—Vomiting—Teniposide—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Diethylpropion—Agitation—Carmustine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Diethylpropion—Rash—Teniposide—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Diethylpropion—Dermatitis—Teniposide—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Diethylpropion—Headache—Teniposide—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Diethylpropion—Leukopenia—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Diethylpropion—Agitation—Vincristine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Diethylpropion—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Diethylpropion—Polyuria—Methotrexate—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Diethylpropion—Diarrhoea—Fludarabine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Diethylpropion—Convulsion—Carmustine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Diethylpropion—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Diethylpropion—Nausea—Teniposide—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Diethylpropion—Leukopenia—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Diethylpropion—Chest pain—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Diethylpropion—Myalgia—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Diethylpropion—Anxiety—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Diethylpropion—Malaise—Mitoxantrone—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Diethylpropion—Dyspnoea—Bleomycin—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diethylpropion—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Diethylpropion—Convulsion—Vincristine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Diethylpropion—Myalgia—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Diethylpropion—Vomiting—Fludarabine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Diethylpropion—Convulsion—Mitoxantrone—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Diethylpropion—Rash—Fludarabine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Diethylpropion—Dermatitis—Fludarabine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Diethylpropion—Headache—Fludarabine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Diethylpropion—Tachycardia—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Diethylpropion—Chest pain—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Diethylpropion—Myalgia—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Diethylpropion—Anxiety—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Diethylpropion—Discomfort—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Diethylpropion—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Diethylpropion—Nausea—Fludarabine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Diethylpropion—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Diethylpropion—Urticaria—Bleomycin—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Diethylpropion—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Diethylpropion—Insomnia—Carmustine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Diethylpropion—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Diethylpropion—Dyspnoea—Carmustine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Diethylpropion—Somnolence—Carmustine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Diethylpropion—Insomnia—Vincristine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Diethylpropion—Constipation—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Diethylpropion—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Diethylpropion—Somnolence—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Diethylpropion—Feeling abnormal—Carmustine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Diethylpropion—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Diethylpropion—Constipation—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Diethylpropion—Constipation—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Diethylpropion—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Diethylpropion—Pancytopenia—Methotrexate—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Diethylpropion—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Diethylpropion—Dysuria—Methotrexate—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Diethylpropion—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Diethylpropion—Urticaria—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Diethylpropion—Vomiting—Bleomycin—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Diethylpropion—Drowsiness—Methotrexate—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Diethylpropion—Rash—Bleomycin—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Diethylpropion—Dermatitis—Bleomycin—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Diethylpropion—Diarrhoea—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Diethylpropion—Nausea—Bleomycin—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Diethylpropion—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Diethylpropion—Dizziness—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Diethylpropion—Diarrhoea—Vincristine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Diethylpropion—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Diethylpropion—Vomiting—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Diethylpropion—Dizziness—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Diethylpropion—Rash—Carmustine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Diethylpropion—Dermatitis—Carmustine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Diethylpropion—Headache—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Diethylpropion—Vomiting—Vincristine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Diethylpropion—Rash—Vincristine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Diethylpropion—Dermatitis—Vincristine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Diethylpropion—Headache—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Diethylpropion—Nausea—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Diethylpropion—Vomiting—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Diethylpropion—Rash—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Diethylpropion—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Diethylpropion—Headache—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Diethylpropion—Alopecia—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Diethylpropion—Erythema—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Diethylpropion—Nausea—Vincristine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Diethylpropion—Nausea—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Diethylpropion—Vision blurred—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Diethylpropion—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Diethylpropion—Malaise—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Diethylpropion—Leukopenia—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Diethylpropion—Convulsion—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Diethylpropion—Chest pain—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Diethylpropion—Myalgia—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Diethylpropion—Discomfort—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Diethylpropion—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Diethylpropion—Insomnia—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Diethylpropion—Dyspnoea—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Diethylpropion—Somnolence—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Diethylpropion—Dyspepsia—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Diethylpropion—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Diethylpropion—Urticaria—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Diethylpropion—Diarrhoea—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Diethylpropion—Dizziness—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Diethylpropion—Vomiting—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Diethylpropion—Rash—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Diethylpropion—Dermatitis—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Diethylpropion—Headache—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Diethylpropion—Nausea—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
